摘要
Despite several advances in targeted therapies for breast cancer,breast-cancer-associated death remains high in women.This is partially due to the lack of reliable markers predicting metastatic disease or recurrence after initial therapy.Recent research into the clinical validity of circulating cancer-specific biomarkers as a“liquid biopsy”is of growing interest.Of these,exosomal microRNAs(miRNAs)are promising candidate biomarkers for clinical use in breast cancer.In addition to their diagnostic value,exosomal miRNAs play an important role in predicting clinical outcome or treatment response.In this review,it is focused on the findings concerning exosomal miRNAs in relation to disease detection,prognostic impact and therapeutic effect in breast cancer,and discuss their clinical utility.
